Variations in Poisoning Epidemiology and Management During the Initial COVID-19 Outbreak in a Taiwanese Emergency Department
- PMID: 40535710
- PMCID: PMC12176141
- DOI: 10.2147/IJGM.S520738
Variations in Poisoning Epidemiology and Management During the Initial COVID-19 Outbreak in a Taiwanese Emergency Department
Abstract
Purpose: The COVID-19 pandemic significantly impacted the epidemiology of emergency department (ED) presentations, including those for self-harm and poisoning. Taiwan, with its strict border controls and quarantine measures, experienced a delayed COVID-19 outbreak in late April 2022. We evaluated epidemiological changes in ED poisoning cases and assessed whether their management was affected during the early stages of the COVID-19 outbreak.
Patients and methods: We conducted a retrospective cohort study of ED poisoning cases during the early phase of the COVID-19 outbreak (May 1-July 31, 2022) and the corresponding pre-COVID-19 periods (May 1-July 31, 2018, and 2019) at a tertiary medical center. Demographic data, poisoning characteristics, treatment efficiency, and clinical outcomes were compared between the two periods.
Results: In total, 145 poisoning cases (48.3 per month) were identified during the pandemic, compared to 572 (95.3 per month) in the pre-pandemic period. Poisoned patients were significantly older (median age: 48 vs 40.5 years, p = 0.009) during the pandemic compared to the pre-pandemic periods, with a significant decline in pediatric poisoning cases. Although an increase in prescription drug exposures and a slight decrease in other poisoning categories was observed, these differences were not statistically significant. The proportion of severe poisoning cases (poisoning severity score 3 or 4) was significantly higher during the pandemic than in the pre-pandemic period (14.5% vs 7.9%, p = 0.021), and was accompanied by increased rates of intubation and intensive care unit admissions. ED stays were significantly prolonged during the pandemic, particularly among patients at risk of concurrent COVID-19 infection. Mortality rates remained comparable between the two periods.
Conclusion: The epidemiology, disease severity, and management efficiency of poisoning cases were significantly affected during the early phase of the nationwide COVID-19 outbreak. Further large-scale studies are needed to validate these findings and inform future interventions.
Keywords: COVID-19 pandemic; SARS-CoV-2; intoxication; overdose.
© 2025 Chen et al.
Conflict of interest statement
The authors declare no conflicts of interest in this work.
Figures
Similar articles
-
Outcomes of pregnant ICU patients with severe COVID-19 pneumonia in Qatar during the three waves of the COVID-19 pandemic: A retrospective cohort study.Qatar Med J. 2025 Feb 26;2025(1):12. doi: 10.5339/qmj.2025.12. eCollection 2025. Qatar Med J. 2025. PMID: 40375859 Free PMC article.
-
Impact of the COVID-19 Pandemic on the Clinical Management of People Living with HIV: A Retrospective Study of 246 Patients at a Single Center.Curr HIV Res. 2025 Jun 16. doi: 10.2174/011570162X360947250605052248. Online ahead of print. Curr HIV Res. 2025. PMID: 40530718
-
Influence of the Enterovirus 71 Vaccine and the COVID-19 Pandemic on Hand, Foot, and Mouth Disease in China Based on Counterfactual Models: Observational Study.JMIR Public Health Surveill. 2024 Dec 17;10:e63146. doi: 10.2196/63146. JMIR Public Health Surveill. 2024. PMID: 39692430 Free PMC article.
-
Prevalence and odds of anxiety and depression in cutaneous malignant melanoma: a proportional meta-analysis and regression.Br J Dermatol. 2024 Jun 20;191(1):24-35. doi: 10.1093/bjd/ljae011. Br J Dermatol. 2024. PMID: 38197404
-
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.Cochrane Database Syst Rev. 2019 Nov 20;2019(11):CD012024. doi: 10.1002/14651858.CD012024.pub3. Cochrane Database Syst Rev. 2019. PMID: 31745984 Free PMC article.
References
-
- Kobayashi S, Sakakura K, Jinnouchi H, et al. Comparison of door-to-balloon time and in-hospital outcomes in patients with ST-elevation myocardial infarction between before versus after COVID-19 pandemic. Cardiovasc Interv Ther. 2022;37(4):641–650. doi: 10.1007/s12928-022-00836-4 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous